BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.

In this photo illustration, the Boston Scientific company logo is seen ... [+] displayed on a smartphone screen. (Photo ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific Corp. engages in the development ... The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral ...